C. Yeh

发表

JAK2 Exon 14 Deletion in Patients with Chronic Myeloproliferative Neoplasms

Xiuqiang Wang, H. Kantarjian, Wanlong Ma, 2010, PloS one.

Circulating heat shock protein 70 and progression in patients with chronic myeloid leukemia.

Z. Estrov, H. Kantarjian, J. Cortes, 2009, Leukemia research.

Plasma levels of JAK2 mRNA in patients with chronic myeloproliferative diseases with and without V617F mutation: implications for prognosis and disease biology

H. Kantarjian, S. Verstovsek, C. Yeh, 2010, International journal of laboratory hematology.

Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasias.

H. Kantarjian, S. Verstovsek, Wanlong Ma, 2009, The Journal of molecular diagnostics : JMD.

Circulating CD33 and its clinical value in acute leukemia.

H. Kantarjian, C. Yeh, S. O'brien, 2010, Experimental hematology.

Somatic Mutations in Cancer-Free Individuals: A Liquid

C. Yeh, Charmaine Brown, Andrew Ford, 2018 .

Involvement of de Novo Ceramide Biosynthesis in Tumor Necrosis Factor-α/Cycloheximide-induced Cerebral Endothelial Cell Death*

D. Choi, C. Yeh, S. Sensi, 1998, The Journal of Biological Chemistry.

MPL Mutation Profile in JAK2 Mutation-negative Patients With Myeloproliferative Disorders

Xiuqiang Wang, Wanlong Ma, Xi Zhang, 2011, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome

Amber C. Donahue, Xiuqiang Wang, H. Kantarjian, 2010, BMC Medical Genetics.

Clinical correlation of circulating heat shock protein 70 in acute leukemia.

E. Estey, Z. Estrov, H. Kantarjian, 2010, Leukemia research.

Circulating Ki-67 protein in plasma as a biomarker and prognostic indicator of acute lymphoblastic leukemia.

Z. Estrov, H. Kantarjian, Wanlong Ma, 2010, Leukemia research.

A cis-Acting Element in Rous Sarcoma Virus Long Terminal Repeat Required for Promoter Repression by HeLa Nuclear Protein p21 (*)

A. Shatkin, C. Yeh, C. Yeh, 1995, The Journal of Biological Chemistry.

Three novel alternative splicing mutations in BCR‐ABL1 detected in CML patients with resistance to kinase inhibitors

C. Yeh, M. Albitar, X. Wang, 2011, International journal of laboratory hematology.

BCR-ABL Truncation due to Premature Translation Termination as a Mechanism of Resistance to Kinase Inhibitors

H. Kantarjian, J. Cortes, Wanlong Ma, 2009, Acta Haematologica.

Effects of Clinically Relevant MPL Mutations in the Transmembrane Domain Revealed at the Atomic Level through Computational Modeling

H. Kantarjian, Tai-Sung Lee, Wanlong Ma, 2011, PloS one.

Detection of BRAF V600E Mutations With Next-Generation Sequencing in Infarcted Thyroid Carcinomas After Fine-Needle Aspiration

U. Manne, C. Yeh, I. Eltoum, 2018, American journal of clinical pathology.

K-ras mutations and cetuximab in colorectal cancer.

Wanlong Ma, C. Yeh, M. Albitar, 2009, The New England journal of medicine.

Exploration of Euchromatin Cell-Free DNA Methylation in Breast Cancer

C. Yeh, Usa Circulogene Theranostics, Usa Circulogene Theranostics, 2020 .

Neutral sphingomyelinase activation in endothelial and glial cell death induced by amyloid beta-peptide

C. Yeh, Ding-I Yang, Jan Xu, 2004, Neurobiology of Disease.

Biological Fragmentation of Circulating Cell-free DNA Alters Genetic Representation

C. Yeh, 2020 .

Next-generation Liquid Biopsy: Tumor Monitoring from Droplet Volumes of Blood

C. Yeh, Andrew Ford, J. Spurgin, 2015 .

Plasma‐based detection of clonality in lymphoid malignancies

C. Yeh, M. Albitar, R. Tseng, 2009, European journal of haematology.

Liquid-based fluorescence in situ hybridization assay for detection of ERBB2 gene amplification in patients with breast cancer.

C. Yeh, M. Albitar, W. Whitmire, 2008, Clinical chemistry.

Circulating Ki-67 index in plasma as a biomarker and prognostic indicator in chronic lymphocytic leukemia.

Amber C. Donahue, Z. Estrov, H. Kantarjian, 2010, Leukemia research.

Enhancement of Outward Potassium Current May Participate in β-Amyloid Peptide-Induced Cortical Neuronal Death

Chen-Hsiung Yeh, Shan Ping Yu, D. Choi, 1998, Neurobiology of Disease.

Next-Generation Targeted Sequencing of Circulating Cell-Free DNA from Droplet Volumes of Blood

C. Yeh, Andrew Ford, J. Spurgin, 2015 .

Drivers of Precision Medicine: Liquid Biopsy and Next-Generation Sequencing

Chen-Hsiung Yeh, C. Yeh, J. Posey, 2016 .

The Ser36-Ser37 Pair in HeLa Nuclear Protein p21/SIIR Mediates Ser/Thr Phosphorylation and Is Essential for Rous Sarcoma Virus Long Terminal Repeat Repression (*)

A. Shatkin, W. Zong, C. Yeh, 1995, The Journal of Biological Chemistry.

Multiplex ligation-dependent probe amplification for detection of chromosomal abnormalities in myelodysplastic syndrome and acute myeloid leukemia.

Amber C. Donahue, C. Yeh, J. Wohlgemuth, 2011, Leukemia research.

Detection, Analysis and Clinical Validation of Chromosomal Aberrations by Multiplex Ligation-Dependent Probe Amplification in Chronic Leukemia

Amber C. Donahue, C. Yeh, J. Wohlgemuth, 2010, PloS one.

Next-Generation Sequencing and Targeted Cancer Therapy

C. Yeh, 2015 .

Sample preparation of circulating cell-free DNA by direct-on-specimen and silica-based methods

C. Yeh, Charmaine Brown, Andrew Ford, 2017 .

Circulating cell-free transcriptomics in cancer

C. Yeh, 2023, Journal of Lung, Pulmonary & Respiratory Research.

Quantification of intracellular proteins and monitoring therapy using flow cytometry.

C. Yeh, M. Albitar, R. Chang, 2010, Current drug targets.

Blood-Drop Liquid Biopsy for Monitoring Mutation Load and Therapeutic Responses

C. Yeh, 2016 .

BCR-ABL truncation due to premature translation termination as a mechanism of resistance to kinase inhibitors.

J. Cortes, C. Yeh, M. Albitar, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pre-Analytical Assessment of Circulating Cell-Free DNA Prepared by An Isolation-Free Enrichment Technology

C. Yeh, Charmaine Brown, Andrew Ford, 2018 .

Clinical Significance of Circulating Ki-67 Protein and Caspase-3 Activity Levels in Chronic Myeloid Leukemia.

Z. Estrov, H. Kantarjian, Wanlong Ma, 2009 .

The Evolution of In Situ Genetic Technology

C. Yeh, Charmaine Brown, Andrew Ford, 2018 .